Global Immuno-oncology Drugs Sales Market Report 2021

Publisher Name :
Date: 14-May-2021
No. of pages: 149
Inquire Before Buying

The global Immuno-oncology Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immuno-oncology Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Immune Checkpoint Inhibitors

- Immune System Modulators

- Cancer Vaccines

- Oncolytic Virus

- Others

Segment by Application

- Hospitals

- Clinics

- Ambulatory Surgical Centers

The Immuno-oncology Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Immuno-oncology Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Amgen, Inc

- AstraZeneca, Plc

- Bristol-Myers Squibb

- Celgene Corporation

- Eli Lilly and Company

- Merck & Co.

- Hoffmann-La Roche AG

- Johnson & Johnson

- Novartis International AG

- AbbVie, Inc.

- Pfizer Inc.

- Sanofi S.A.

- EMD Serono, Inc.

- Gilead Sciences Inc.

- Prometheus Therapeutics & Diagnostics

- Aduro BioTech

- Galena Biopharma

- Bavarian Nordic

- Celldex Therapeutics

- ImmunoCellular Therapeutics

- Incyte

- Dendreon Corporation

- Agilent Technologies Inc.

- Agenus Inc.

- Enzo Biochem, Inc.

- Lonza Group

- Bio-Rad Laboratories, Inc.

- Avantor, Inc.

- Spring Bank Pharmaceuticals, Inc.

- Ferring Pharmaceuticals

Global Immuno-oncology Drugs Sales Market Report 2021

Table of Contents
1 Immuno-oncology Drugs Market Overview
1.1 Immuno-oncology Drugs Product Scope
1.2 Immuno-oncology Drugs Segment by Type
1.2.1 Global Immuno-oncology Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Immune System Modulators
1.2.4 Cancer Vaccines
1.2.5 Oncolytic Virus
1.2.6 Others
1.3 Immuno-oncology Drugs Segment by Application
1.3.1 Global Immuno-oncology Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Immuno-oncology Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Immuno-oncology Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Immuno-oncology Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Immuno-oncology Drugs Price Trends (2016-2027)
2 Immuno-oncology Drugs Estimates and Forecasts by Region
2.1 Global Immuno-oncology Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Immuno-oncology Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Immuno-oncology Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Immuno-oncology Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Immuno-oncology Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Immuno-oncology Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Immuno-oncology Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Immuno-oncology Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Immuno-oncology Drugs Estimates and Projections (2016-2027)
2.4.3 China Immuno-oncology Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Immuno-oncology Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Immuno-oncology Drugs Estimates and Projections (2016-2027)
2.4.6 India Immuno-oncology Drugs Estimates and Projections (2016-2027)
3 Global Immuno-oncology Drugs Competition Landscape by Players
3.1 Global Top Immuno-oncology Drugs Players by Sales (2016-2021)
3.2 Global Top Immuno-oncology Drugs Players by Revenue (2016-2021)
3.3 Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immuno-oncology Drugs as of 2020)
3.4 Global Immuno-oncology Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Immuno-oncology Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Immuno-oncology Drugs Market Size by Type
4.1 Global Immuno-oncology Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Immuno-oncology Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Immuno-oncology Drugs Price by Type (2016-2021)
4.2 Global Immuno-oncology Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Immuno-oncology Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Immuno-oncology Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Immuno-oncology Drugs Price Forecast by Type (2022-2027)
5 Global Immuno-oncology Drugs Market Size by Application
5.1 Global Immuno-oncology Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Immuno-oncology Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Immuno-oncology Drugs Price by Application (2016-2021)
5.2 Global Immuno-oncology Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Immuno-oncology Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Immuno-oncology Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Immuno-oncology Drugs Price Forecast by Application (2022-2027)
6 North America Immuno-oncology Drugs Market Facts & Figures
6.1 North America Immuno-oncology Drugs Sales by Company
6.1.1 North America Immuno-oncology Drugs Sales by Company (2016-2021)
6.1.2 North America Immuno-oncology Drugs Revenue by Company (2016-2021)
6.2 North America Immuno-oncology Drugs Sales Breakdown by Type
6.2.1 North America Immuno-oncology Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Immuno-oncology Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Immuno-oncology Drugs Sales Breakdown by Application
6.3.1 North America Immuno-oncology Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Immuno-oncology Drugs Sales Breakdown by Application (2022-2027)
7 Europe Immuno-oncology Drugs Market Facts & Figures
7.1 Europe Immuno-oncology Drugs Sales by Company
7.1.1 Europe Immuno-oncology Drugs Sales by Company (2016-2021)
7.1.2 Europe Immuno-oncology Drugs Revenue by Company (2016-2021)
7.2 Europe Immuno-oncology Drugs Sales Breakdown by Type
7.2.1 Europe Immuno-oncology Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Immuno-oncology Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Immuno-oncology Drugs Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Immuno-oncology Drugs Market Facts & Figures
8.1 China Immuno-oncology Drugs Sales by Company
8.1.1 China Immuno-oncology Drugs Sales by Company (2016-2021)
8.1.2 China Immuno-oncology Drugs Revenue by Company (2016-2021)
8.2 China Immuno-oncology Drugs Sales Breakdown by Type
8.2.1 China Immuno-oncology Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Immuno-oncology Drugs Sales Breakdown by Type (2022-2027)
8.3 China Immuno-oncology Drugs Sales Breakdown by Application
8.3.1 China 172 Sales Breakdown by Application (2016-2021)
8.3.2 China 172 Sales Breakdown by Application (2022-2027)
9 Japan Immuno-oncology Drugs Market Facts & Figures
9.1 Japan Immuno-oncology Drugs Sales by Company
9.1.1 Japan Immuno-oncology Drugs Sales by Company (2016-2021)
9.1.2 Japan Immuno-oncology Drugs Revenue by Company (2016-2021)
9.2 Japan Immuno-oncology Drugs Sales Breakdown by Type
9.2.1 Japan Immuno-oncology Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Immuno-oncology Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Immuno-oncology Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Immuno-oncology Drugs Market Facts & Figures
10.1 Southeast Asia Immuno-oncology Drugs Sales by Company
10.1.1 Southeast Asia Immuno-oncology Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Immuno-oncology Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Immuno-oncology Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Immuno-oncology Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Immuno-oncology Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Immuno-oncology Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Immuno-oncology Drugs Market Facts & Figures
11.1 India Immuno-oncology Drugs Sales by Company
11.1.1 India Immuno-oncology Drugs Sales by Company (2016-2021)
11.1.2 India Immuno-oncology Drugs Revenue by Company (2016-2021)
11.2 India Immuno-oncology Drugs Sales Breakdown by Type
11.2.1 India Immuno-oncology Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Immuno-oncology Drugs Sales Breakdown by Type (2022-2027)
11.3 India Immuno-oncology Drugs Sales Breakdown by Application
11.3.1 India Immuno-oncology Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Immuno-oncology Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Immuno-oncology Drugs Business
12.1 Amgen, Inc
12.1.1 Amgen, Inc Corporation Information
12.1.2 Amgen, Inc Business Overview
12.1.3 Amgen, Inc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen, Inc Immuno-oncology Drugs Products Offered
12.1.5 Amgen, Inc Recent Development
12.2 AstraZeneca, Plc
12.2.1 AstraZeneca, Plc Corporation Information
12.2.2 AstraZeneca, Plc Business Overview
12.2.3 AstraZeneca, Plc Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca, Plc Immuno-oncology Drugs Products Offered
12.2.5 AstraZeneca, Plc Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Corporation Information
12.3.2 Bristol-Myers Squibb Business Overview
12.3.3 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Corporation Information
12.4.2 Celgene Corporation Business Overview
12.4.3 Celgene Corporation Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Celgene Corporation Immuno-oncology Drugs Products Offered
12.4.5 Celgene Corporation Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Corporation Information
12.5.2 Eli Lilly and Company Business Overview
12.5.3 Eli Lilly and Company Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Eli Lilly and Company Immuno-oncology Drugs Products Offered
12.5.5 Eli Lilly and Company Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Corporation Information
12.6.2 Merck & Co. Business Overview
12.6.3 Merck & Co. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Merck & Co. Immuno-oncology Drugs Products Offered
12.6.5 Merck & Co. Recent Development
12.7 Hoffmann-La Roche AG
12.7.1 Hoffmann-La Roche AG Corporation Information
12.7.2 Hoffmann-La Roche AG Business Overview
12.7.3 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Products Offered
12.7.5 Hoffmann-La Roche AG Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Corporation Information
12.8.2 Johnson & Johnson Business Overview
12.8.3 Johnson & Johnson Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Johnson & Johnson Immuno-oncology Drugs Products Offered
12.8.5 Johnson & Johnson Recent Development
12.9 Novartis International AG
12.9.1 Novartis International AG Corporation Information
12.9.2 Novartis International AG Business Overview
12.9.3 Novartis International AG Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Novartis International AG Immuno-oncology Drugs Products Offered
12.9.5 Novartis International AG Recent Development
12.10 AbbVie, Inc.
12.10.1 AbbVie, Inc. Corporation Information
12.10.2 AbbVie, Inc. Business Overview
12.10.3 AbbVie, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 AbbVie, Inc. Immuno-oncology Drugs Products Offered
12.10.5 AbbVie, Inc. Recent Development
12.11 Pfizer Inc.
12.11.1 Pfizer Inc. Corporation Information
12.11.2 Pfizer Inc. Business Overview
12.11.3 Pfizer Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Inc. Immuno-oncology Drugs Products Offered
12.11.5 Pfizer Inc. Recent Development
12.12 Sanofi S.A.
12.12.1 Sanofi S.A. Corporation Information
12.12.2 Sanofi S.A. Business Overview
12.12.3 Sanofi S.A. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Sanofi S.A. Immuno-oncology Drugs Products Offered
12.12.5 Sanofi S.A. Recent Development
12.13 EMD Serono, Inc.
12.13.1 EMD Serono, Inc. Corporation Information
12.13.2 EMD Serono, Inc. Business Overview
12.13.3 EMD Serono, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 EMD Serono, Inc. Immuno-oncology Drugs Products Offered
12.13.5 EMD Serono, Inc. Recent Development
12.14 Gilead Sciences Inc.
12.14.1 Gilead Sciences Inc. Corporation Information
12.14.2 Gilead Sciences Inc. Business Overview
12.14.3 Gilead Sciences Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Gilead Sciences Inc. Immuno-oncology Drugs Products Offered
12.14.5 Gilead Sciences Inc. Recent Development
12.15 Prometheus Therapeutics & Diagnostics
12.15.1 Prometheus Therapeutics & Diagnostics Corporation Information
12.15.2 Prometheus Therapeutics & Diagnostics Business Overview
12.15.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Products Offered
12.15.5 Prometheus Therapeutics & Diagnostics Recent Development
12.16 Aduro BioTech
12.16.1 Aduro BioTech Corporation Information
12.16.2 Aduro BioTech Business Overview
12.16.3 Aduro BioTech Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Aduro BioTech Immuno-oncology Drugs Products Offered
12.16.5 Aduro BioTech Recent Development
12.17 Galena Biopharma
12.17.1 Galena Biopharma Corporation Information
12.17.2 Galena Biopharma Business Overview
12.17.3 Galena Biopharma Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Galena Biopharma Immuno-oncology Drugs Products Offered
12.17.5 Galena Biopharma Recent Development
12.18 Bavarian Nordic
12.18.1 Bavarian Nordic Corporation Information
12.18.2 Bavarian Nordic Business Overview
12.18.3 Bavarian Nordic Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Bavarian Nordic Immuno-oncology Drugs Products Offered
12.18.5 Bavarian Nordic Recent Development
12.19 Celldex Therapeutics
12.19.1 Celldex Therapeutics Corporation Information
12.19.2 Celldex Therapeutics Business Overview
12.19.3 Celldex Therapeutics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Celldex Therapeutics Immuno-oncology Drugs Products Offered
12.19.5 Celldex Therapeutics Recent Development
12.20 ImmunoCellular Therapeutics
12.20.1 ImmunoCellular Therapeutics Corporation Information
12.20.2 ImmunoCellular Therapeutics Business Overview
12.20.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 ImmunoCellular Therapeutics Immuno-oncology Drugs Products Offered
12.20.5 ImmunoCellular Therapeutics Recent Development
12.21 Incyte
12.21.1 Incyte Corporation Information
12.21.2 Incyte Business Overview
12.21.3 Incyte Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Incyte Immuno-oncology Drugs Products Offered
12.21.5 Incyte Recent Development
12.22 Dendreon Corporation
12.22.1 Dendreon Corporation Corporation Information
12.22.2 Dendreon Corporation Business Overview
12.22.3 Dendreon Corporation Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Dendreon Corporation Immuno-oncology Drugs Products Offered
12.22.5 Dendreon Corporation Recent Development
12.23 Agilent Technologies Inc.
12.23.1 Agilent Technologies Inc. Corporation Information
12.23.2 Agilent Technologies Inc. Business Overview
12.23.3 Agilent Technologies Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Agilent Technologies Inc. Immuno-oncology Drugs Products Offered
12.23.5 Agilent Technologies Inc. Recent Development
12.24 Agenus Inc.
12.24.1 Agenus Inc. Corporation Information
12.24.2 Agenus Inc. Business Overview
12.24.3 Agenus Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Agenus Inc. Immuno-oncology Drugs Products Offered
12.24.5 Agenus Inc. Recent Development
12.25 Enzo Biochem, Inc.
12.25.1 Enzo Biochem, Inc. Corporation Information
12.25.2 Enzo Biochem, Inc. Business Overview
12.25.3 Enzo Biochem, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Enzo Biochem, Inc. Immuno-oncology Drugs Products Offered
12.25.5 Enzo Biochem, Inc. Recent Development
12.26 Lonza Group
12.26.1 Lonza Group Corporation Information
12.26.2 Lonza Group Business Overview
12.26.3 Lonza Group Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Lonza Group Immuno-oncology Drugs Products Offered
12.26.5 Lonza Group Recent Development
12.27 Bio-Rad Laboratories, Inc.
12.27.1 Bio-Rad Laboratories, Inc. Corporation Information
12.27.2 Bio-Rad Laboratories, Inc. Business Overview
12.27.3 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Bio-Rad Laboratories, Inc. Immuno-oncology Drugs Products Offered
12.27.5 Bio-Rad Laboratories, Inc. Recent Development
12.28 Avantor, Inc.
12.28.1 Avantor, Inc. Corporation Information
12.28.2 Avantor, Inc. Business Overview
12.28.3 Avantor, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.28.4 Avantor, Inc. Immuno-oncology Drugs Products Offered
12.28.5 Avantor, Inc. Recent Development
12.29 Spring Bank Pharmaceuticals, Inc.
12.29.1 Spring Bank Pharmaceuticals, Inc. Corporation Information
12.29.2 Spring Bank Pharmaceuticals, Inc. Business Overview
12.29.3 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.29.4 Spring Bank Pharmaceuticals, Inc. Immuno-oncology Drugs Products Offered
12.29.5 Spring Bank Pharmaceuticals, Inc. Recent Development
12.30 Ferring Pharmaceuticals
12.30.1 Ferring Pharmaceuticals Corporation Information
12.30.2 Ferring Pharmaceuticals Business Overview
12.30.3 Ferring Pharmaceuticals Immuno-oncology Drugs Sales, Revenue and Gross Margin (2016-2021)
12.30.4 Ferring Pharmaceuticals Immuno-oncology Drugs Products Offered
12.30.5 Ferring Pharmaceuticals Recent Development
13 Immuno-oncology Drugs Manufacturing Cost Analysis
13.1 Immuno-oncology Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Immuno-oncology Drugs
13.4 Immuno-oncology Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Immuno-oncology Drugs Distributors List
14.3 Immuno-oncology Drugs Customers
15 Market Dynamics
15.1 Immuno-oncology Drugs Market Trends
15.2 Immuno-oncology Drugs Drivers
15.3 Immuno-oncology Drugs Market Challenges
15.4 Immuno-oncology Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Immuno-oncology Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Immuno-oncology Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Immuno-oncology Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Immuno-oncology Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Immuno-oncology Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Immuno-oncology Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Immuno-oncology Drugs Revenue Share by Region (2016-2021)
Table 8. Global Immuno-oncology Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Immuno-oncology Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Immuno-oncology Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Immuno-oncology Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Immuno-oncology Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Immuno-oncology Drugs Sales Share by Company (2016-2021)
Table 14. Global Immuno-oncology Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Immuno-oncology Drugs Revenue Share by Company (2016-2021)
Table 16. Global Immuno-oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-oncology Drugs as of 2020)
Table 17. Global Immuno-oncology Drugs Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Immuno-oncology Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Immuno-oncology Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Immuno-oncology Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Immuno-oncology Drugs Sales Share by Type (2016-2021)
Table 23. Global Immuno-oncology Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Immuno-oncology Drugs Price (USD/Unit) by Type (2016-2021)
Table 25. Global Immuno-oncology Drugs Sales Share by Type (2022-2027)
Table 26. Global Immuno-oncology Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Immuno-oncology Drugs Revenue Share by Type (2022-2027)
Table 28. Global Immuno-oncology Drugs Price (USD/Unit) by Type (2022-2027)
Table 29. Global Immuno-oncology Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Immuno-oncology Drugs Sales Share by Application (2016-2021)
Table 31. Global Immuno-oncology Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Immuno-oncology Drugs Price (USD/Unit) by Application (2016-2021)
Table 33. Global Immuno-oncology Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Immuno-oncology Drugs Sales Share by Application (2022-2027)
Table 35. Global Immuno-oncology Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Immuno-oncology Drugs Revenue Share by Application (2022-2027)
Table 37. Global Immuno-oncology Drugs Price (USD/Unit) by Application (2022-2027)
Table 38. North America Immuno-oncology Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Immuno-oncology Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Immuno-oncology Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Immuno-oncology Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Immuno-oncology Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Immuno-oncology Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Immuno-oncology Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Immuno-oncology Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Immuno-oncology Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Immuno-oncology Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Immuno-oncology Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Immuno-oncology Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Immuno-oncology Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Immuno-oncology Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Immuno-oncology Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Immuno-oncology Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Immuno-oncology Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Immuno-oncology Drugs Sales Market Share by Application (2022-2027)
Table 62. China Immuno-oncology Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Table 64. China Immuno-oncology Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Immuno-oncology Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Immuno-oncology Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Table 68. China Immuno-oncology Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Immuno-oncology Drugs Sales Market Share by Type (2022-2027)
Table 70. China Immuno-oncology Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Table 72. China Immuno-oncology Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Immuno-oncology Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Immuno-oncology Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Immuno-oncology Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Immuno-oncology Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Immuno-oncology Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Immuno-oncology Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Immuno-oncology Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Immuno-oncology Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Immuno-oncology Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Immuno-oncology Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Immuno-oncology Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Immuno-oncology Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Immuno-oncology Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Immuno-oncology Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Immuno-oncology Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Immuno-oncology Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Immuno-oncology Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Immuno-oncology Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Immuno-oncology Drugs Sales Market Share by Application (2022-2027)
Table 98. India Immuno-oncology Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Immuno-oncology Drugs Sales Market Share by Company (2016-2021)
Table 100. India Immuno-oncology Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Immuno-oncology Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Immuno-oncology Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Immuno-oncology Drugs Sales Market Share by Type (2016-2021)
Table 104. India Immuno-oncology Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Immuno-oncology Drugs Sales Market Share by Type (2022-2027)
Table 106. India Immuno-oncology Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Immuno-oncology Drugs Sales Market Share by Application (2016-2021)
Table 108. India Immuno-oncology Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Immuno-oncology Drugs Sales Market Share by Application (2022-2027)
Table 110. Amgen, Inc Corporation Information
Table 111. Amgen, Inc Description and Business Overview
Table 112. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Amgen, Inc Immuno-oncology Drugs Product
Table 114. Amgen, Inc Recent Development
Table 115. AstraZeneca, Plc Corporation Information
Table 116. AstraZeneca, Plc Description and Business Overview
Table 117. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. AstraZeneca, Plc Immuno-oncology Drugs Product
Table 119. AstraZeneca, Plc Recent Development
Table 120. Bristol-Myers Squibb Corporation Information
Table 121. Bristol-Myers Squibb Description and Business Overview
Table 122. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Bristol-Myers Squibb Immuno-oncology Drugs Product
Table 124. Bristol-Myers Squibb Recent Development
Table 125. Celgene Corporation Corporation Information
Table 126. Celgene Corporation Description and Business Overview
Table 127. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Celgene Corporation Immuno-oncology Drugs Product
Table 129. Celgene Corporation Recent Development
Table 130. Eli Lilly and Company Corporation Information
Table 131. Eli Lilly and Company Description and Business Overview
Table 132. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Eli Lilly and Company Immuno-oncology Drugs Product
Table 134. Eli Lilly and Company Recent Development
Table 135. Merck & Co. Corporation Information
Table 136. Merck & Co. Description and Business Overview
Table 137. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (Millio
  • Global Beta-lactam and Beta-lactamase Inhibitors Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 102
    The Beta-lactam and Beta-lactamase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Accor......
  • Global Anti-aging Ingredients Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 105
    The Anti-aging Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest ......
  • Global BRAF Kinase Inhibitors Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 103
    The BRAF Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest ......
  • Global Orthostatic Hypotension Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 105
    The Orthostatic Hypotension Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our ......
  • Global Gallbladder Cancer Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 105
    The Gallbladder Cancer Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to ou......
  • Global Obsessive-Compulsive Disorder Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 104
    The Obsessive-Compulsive Disorder Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According t......
  • Global Female Sexual Dysfunction Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 107
    The Female Sexual Dysfunction Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According t......
  • Global Age-Related Macular Degeneration (AMD) Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 100
    The Age-Related Macular Degeneration (AMD) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. ......
  • Global Upper Respiratory Tract Infection Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 23-Jun-2021        Price: US 3480 Onwards        Pages: 103
    The Upper Respiratory Tract Infection Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. Acc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs